THERAPEUTICSMD, INC.

Profile

Company Names

THERAPEUTICSMD, INC.

Addresses

951 YAMATO ROAD, SUITE 220, BOCA RATON, FL 33431

951 YAMATO ROAD, SUITE 220, BOCA RATON, FL 33431

951 BROKEN SOUND PARKWAY NW, SUITE 320, BOCA RATON, FL 33487

Phone Numbers

561-961-1900
561-961-1911

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2010

State Incorporated:

NEVADA

Total Amount Raised:

$46,149,999.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-06-29 
$1,149,998.00 
$5,000,000.00 
$3,850,002.00 
Equity 
5
2022-10-28 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
4
2022-09-30 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
3
2022-07-29 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
2
2020-08-05 
$7,500,000.00 
$7,500,000.00 
$0.00 
 
1
2012-09-26 
$8,500,001.00 
$8,500,001.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
BERNICK 
EXECUTIVE OFFICER
BRIAN 
 
BERNICK, M.D. 
EXECUTIVE OFFICER, DIRECTOR
PAUL 
 
BISARO 
DIRECTOR
PAUL 
M. 
BISARO 
DIRECTOR
EDWARD 
 
BORKOWSKI 
EXECUTIVE OFFICER
J. 
MARTIN 
CARROLL 
DIRECTOR
DANIEL 
A. 
CARTWRIGHT 
EXECUTIVE OFFICER
COOPER 
C. 
COLLINS 
DIRECTOR
JAMES 
C. 
D-ARECCA 
EXECUTIVE OFFICER
MICHAEL 
 
DONEGAN 
EXECUTIVE OFFICER
MICHAEL 
C. 
DONEGAN 
EXECUTIVE OFFICER
ROBERT 
G. 
FINIZIO 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
GLICKMAN 
EXECUTIVE OFFICER
SAMUEL 
A. 
GRECO 
DIRECTOR
MITCHELL 
L. 
KRASSAN 
EXECUTIVE OFFICER
ROBERT 
V. 
LAPENTA, JR. 
DIRECTOR
KAREN 
 
LING 
DIRECTOR
KAREN 
L. 
LING 
DIRECTOR
JOHN 
C.K. 
MILLIGAN IV 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
C.K. 
MILLIGAN, IV 
EXECUTIVE OFFICER
JULES 
A. 
MUSING 
DIRECTOR
GAIL 
 
NAUGHTON 
DIRECTOR
GAIL 
K. 
NAUGHTON 
DIRECTOR
HUGH 
 
O-DOWD 
EXECUTIVE OFFICER, DIRECTOR
JUSTIN 
 
ROBERTS 
DIRECTOR
ANGUS 
C. 
RUSSELL 
DIRECTOR
NICHOLAS 
 
SEGAL 
DIRECTOR
MARLAN 
 
WALKER 
EXECUTIVE OFFICER
MARLAN 
D. 
WALKER 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-06-29 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-10-28 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-29 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-08-05 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-09-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GREENHILL + CO. LLC
NONE
NONE
JEFFERIES + COMPANY, INC.